Once data from final analysis of phase III studies are available, Bharat Biotech will ... - Latest Tweet by ANI

The latest Tweet by ANI states, 'Once data from final analysis of phase III studies are available, Bharat Biotech will apply for full licensure for COVAXIN: Bharat Biotech'

(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)

Share Now